Headlines

Allergan Will Say No Thanks to $46 Billion Take-Over Bid

Published

12 years ago

May 12, 2014

INVISION Staff

The company says Valeant would cut back on research.

Reports say that Botox-maker Allergan this week will reject the $46 billion take-over offer from rival Valeant Pharmaceuticals, which recently acquired Bausch & Lomb, setting the stage for what the Financial Times calls “a hostile takeover battle at the top of the US drugmaking industry.” Allergan is expected to raise concerns that Valeant would cut research and development as a reason for refusing the offer. The acquisition would create the pre-eminent global powerhouse in the eyecare industry.

Cherry Optical Lab

Rooted in the Pursuit of Excellence.

Cherry Optical Lab is a family-owned, Independent wholesale optical Laboratory that produces lenses 24 hours a day, 5+ days a week, and is obsessed with making two things:

1. The world’s best lenses

2. The world’s Happiest Humans*

*Our team members, our customers, and their customers

We boldly believe that our job is to serve Eye Care Professionals and deliver excellence for patients, regardless of the prescription. That’s why we offer accelerated turnaround times for high-quality, high-standard lenses made by craftspeople who hold the same certifications as opticians.

All this is our effort to give Eye Care Professionals more ways to say “Yes” to their patients.

Learn More.